Repository logo
 
Publication

Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019

dc.contributor.authorKissling, Esther
dc.contributor.authorRose, Angela
dc.contributor.authorEmborg, Hanne-Dorthe
dc.contributor.authorGherasim, Alin
dc.contributor.authorPebody, Richard
dc.contributor.authorPozo, Francisco
dc.contributor.authorTrebbien, Ramona
dc.contributor.authorMazagatos, Clara
dc.contributor.authorWhitaker, Heather
dc.contributor.authorValenciano, Marta
dc.contributor.authorEuropean IVE group
dc.date.accessioned2020-05-02T15:38:51Z
dc.date.available2020-05-02T15:38:51Z
dc.date.issued2019-02-21
dc.descriptionEuropean IVE Group - Portuguese Team: Verónica Gomez, Irina Kislaya, Baltazar Nunes, Ana Paula Rodrigues Ausenda Machado (Departamento de Epidemiologia, Instituto Nacional de Saúde Doutor Ricardo Jorge); Patrícia Conde, Inês Costa, Paula Cristóvão, Pedro Pechirra, Raquel Guiomar (Departamento de Doenças Infeciosas, Instituto Nacional de Saúde Doutor Ricardo Jorge).pt_PT
dc.description.abstractSeasonal influenza vaccine is recommended in all European Union (EU) countries for older people and others at increased risk of severe influenza and its complications, including those with chronic diseases. In the United Kingdom (UK), incremental introduction of a universal childhood influenza vaccination programme began in 2013/14. The World Health Organization (WHO) recommendations for trivalent influenza vaccine strains for the 2018/19 northern hemisphere influenza season included an A/Michigan/45/2015 (H1N1)pdm09-like virus, an A/Singapore/INFIMH-16–0019/2016 (H3N2)-like virus and a B/Colorado/06/2017-like virus from the B/Victoria lineage. The early 2018/19 influenza season in Europe was characterised by both influenza A virus subtypes circulating widely. There was co-circulation in some countries, with others reporting dominance of either A(H1N1)pdm09 or A(H3N2) viruses. The season started late in most countries compared with previous seasons, with few influenza B viruses detected in the WHO European Region. Since the 2008/09 season, the UK, Denmark, Spain, and several other EU countries conducting multicentre studies, have participated in I-MOVE (Influenza – Monitoring Vaccine Effectiveness in Europe), a network measuring influenza vaccine effectiveness each season. Interim results from six established influenza VE studies across Europe for the 2018/19 season indicate that VE against laboratory-confirmed influenza A ranged between 32% and 43% among all ages in primary care and hospital settings and was 59% in the target groups for vaccination.pt_PT
dc.description.sponsorshipECDCpt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationEuro Surveill. 2019 Feb;24(8):pii=1900121. doi: 10.2807/1560-7917.ES.2019.24.1900121pt_PT
dc.identifier.doihttps://doi.org/10.2807/1560-7917.ES.2019.24.1900121pt_PT
dc.identifier.issn1560-7917
dc.identifier.urihttp://hdl.handle.net/10400.18/6575
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherEuropean Centre for Disease Prevention and Controlpt_PT
dc.relation.publisherversionhttps://eurosurveillance.org/content/10.2807/1560-7917.ES.2019.24.1900121pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectInfluenzapt_PT
dc.subjectVaccine Effectivenesspt_PT
dc.subjectVaccines and Immunisationpt_PT
dc.subjectEuropept_PT
dc.subjectMulticentre Studypt_PT
dc.subjectTest-negative Designpt_PT
dc.subjectVaccinationpt_PT
dc.subjectEuroEVApt_PT
dc.subjectGripept_PT
dc.subjectVacinapt_PT
dc.subjectEfetividadept_PT
dc.subjectDeterminantes da Saúde e da Doençapt_PT
dc.titleInterim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019pt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.issue8pt_PT
oaire.citation.startPagepii=1900121pt_PT
oaire.citation.titleEurosurveillancept_PT
oaire.citation.volume4pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
EuroSurveillance 24_8_Feb2019.pdf
Size:
5.92 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: